You are here:
Information letter on Ammonaps® (sodium phenylbutyrate) tablets and granules: Treatment only if no alternative is available
2016.12.13
Active substance: sodium phenylbutyrate
In view of failings found in the manufacturing site of Ammonaps® (sodium phenylbutyrate) the company Swedish Orphan Biovitrum International AB (Sobi) is circulating information on temporary precautionary measures regarding treatment with Ammonaps® tablets and granules.
Download DHPC / Information letter , Download_VeroeffentlichtAm_EN